New Research from the 2016 San Antonio Breast Cancer Symposium

December 28, 2016
Monika Joshi, ASCO Staff

Julie Gralow, MD, of the University of Washington and the Seattle Cancer Care Alliance, recently attended the San Antonio Breast Cancer Symposium. Dr. Gralow is also a member of Cancer.Net’s Editorial Board. In this podcast, she discusses the major points of this year’s symposium: better, more targeted treatments and managing side effects. share on twitter These highlights include:

  • Strategies in the use of hormonal therapy, or endocrine therapy, in the treatment of early-stage breast cancer and metastatic breast cancer, in particular aromatase inhibitors and PI-3 kinase inhibitors [1:32].

  • An update on HER2-positive metastatic breast cancer research [8:57].

  • Research on the use of PARP inhibitors in the treatment of triple-negative breast cancer [10:37].

  • Helping relieve joint and muscle pain in women taking aromatase inhibitors [12:28].

This is a prerecorded audio podcast. It can be listened to online or downloaded to your computer. A transcript of this podcast is also available. For more information, visit the Cancer.Net podcast page.